Knott David M Jr - Q3 2022 holdings

$238 Million is the total value of Knott David M Jr's 192 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 74.2% .

 Value Shares↓ Weighting
BBIO SellBridgebio Pharma, Inc.$1,422,000
-26.5%
143,096
-32.9%
0.60%
-26.4%
INCY SellIncyte Corporation$1,083,000
-67.5%
16,257
-62.9%
0.46%
-67.4%
FSK SellFS KKR Capital Corp.$257,000
-61.0%
15,175
-55.3%
0.11%
-61.0%
OXY SellOccidental Petroleum Corporation$78,0000.0%1,273
-11.0%
0.03%0.0%
IJR SellIshares Trust Core S&P Small Cap$27,000
-42.6%
313
-38.6%
0.01%
-45.0%
SellStronghold Digital Mining, Inc.$9,000
-97.3%
9,085
-95.4%
0.00%
-97.1%
VZ SellVerizon Communications Inc.$10,000
-98.8%
263
-98.5%
0.00%
-98.9%
DBRG SellDigitalBridge Group, Inc.$5,000
-28.6%
366
-75.0%
0.00%
-33.3%
SVC ExitService Properties Trust$0-1,000
-100.0%
-0.00%
RPV ExitInvesco S&P 500 Pure Value ETF$0-78
-100.0%
-0.00%
VNQ ExitVanguard Real Estate Index Fund ETF Shares$0-74
-100.0%
-0.00%
RSP ExitInvesco S&P 500 Equal Weight ETF$0-96
-100.0%
-0.01%
ExitGeneral Electric Company$0-312
-100.0%
-0.01%
BRPM ExitB. Riley Principal 150 Merger Corp.$0-2,000
-100.0%
-0.01%
ExitQuanta Services Inc.$0-176
-100.0%
-0.01%
ExitBecton Dickinson & Co$0-106
-100.0%
-0.01%
MIC ExitMacquarie Infrastructure Holdings, LLC$0-10,350
-100.0%
-0.02%
XBI ExitSPDR S&P Biotech ETF$0-800
-100.0%
-0.02%
ETTX ExitEntasis Therapeutics Holding$0-41,700
-100.0%
-0.04%
WARRWS ExitWarrior Technologies Acquisition Comp Wt$0-12,500
-100.0%
-0.06%
IVV ExitiShares Core S&P 500 ETF$0-429
-100.0%
-0.07%
WARR ExitWarrior Technologies Acquisition Company$0-25,000
-100.0%
-0.10%
T ExitAT&T Inc.$0-20,000
-100.0%
-0.18%
BRPMW ExitB. Riley Principal 150 Merger Corp. Wts$0-58,321
-100.0%
-0.28%
KFT ExitMondelez International Inc.$0-14,000
-100.0%
-0.36%
RDUS ExitRadius Health Inc.$0-97,888
-100.0%
-0.43%
REGN ExitRegeneron Pharmaceuticals, Inc.$0-2,500
-100.0%
-0.62%
INVA ExitInnoviva, Inc.$0-115,269
-100.0%
-0.71%
SRRA ExitSierra Oncology$0-55,758
-100.0%
-1.29%
BHVN ExitBiohaven Pharmaceutical Holding Co. Ltd$0-25,051
-100.0%
-1.53%
APO ExitApollo Global Management, Inc.$0-225,000
-100.0%
-4.58%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-11-10
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Calumet Specialty Products Partners, LP8Q3 202331.5%
Alphabet Inc-Cl C8Q3 20235.6%
DocGo, Inc.8Q3 20235.8%
Ligand Pharmaceuticals Incorporated8Q3 20234.3%
Franklin BSP Realty Trust, Inc.8Q3 20234.9%
Midwest Holding Inc.8Q3 20234.1%
Coliseum Acquisition Corp.WTS8Q3 20232.4%
Pfizer Inc.8Q3 20233.2%
Jazz Pharmaceuticals PLC8Q3 20231.5%
Vertex Pharmaceuticals, Inc.8Q3 20232.1%

View Knott David M Jr's complete holdings history.

Latest significant ownerships (13-D/G)
Knott David M Jr Q3 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Calumet Specialty Products Partners, L.P.November 08, 20214,292,2005.4%

View Knott David M Jr's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
42023-12-22
SC 13D/A2023-12-22
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-11
13F-HR2023-02-13
13F-HR2022-11-10
42022-09-26
42022-09-02

View Knott David M Jr's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (237627000.0 != 237629000.0)

Export Knott David M Jr's holdings